- Home
- ARQQ vs BWAY Comparison
ARQQ vs BWAY Comparison
Compare ARQQ & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- BWAY
- Stock Information
- Founded
- ARQQ 2017
- BWAY 2003
- Country
- ARQQ United Kingdom
- BWAY Israel
- Employees
- ARQQ N/A
- BWAY N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- BWAY Medical/Dental Instruments
- Sector
- ARQQ Technology
- BWAY Health Care
- Exchange
- ARQQ Nasdaq
- BWAY Nasdaq
- Market Cap
- ARQQ 194.9M
- BWAY 207.4M
- IPO Year
- ARQQ N/A
- BWAY 2019
- Fundamental
- Price
- ARQQ $15.84
- BWAY $8.76
- Analyst Decision
- ARQQ Strong Buy
- BWAY Strong Buy
- Analyst Count
- ARQQ 1
- BWAY 3
- Target Price
- ARQQ $52.00
- BWAY $13.17
- AVG Volume (30 Days)
- ARQQ 292.9K
- BWAY 24.0K
- Earning Date
- ARQQ 05-19-2025
- BWAY 05-13-2025
- Dividend Yield
- ARQQ N/A
- BWAY N/A
- EPS Growth
- ARQQ N/A
- BWAY N/A
- EPS
- ARQQ N/A
- BWAY 0.06
- Revenue
- ARQQ $293,000.00
- BWAY $41,016,000.00
- Revenue This Year
- ARQQ $1,818.77
- BWAY $351.53
- Revenue Next Year
- ARQQ N/A
- BWAY $21.84
- P/E Ratio
- ARQQ N/A
- BWAY $57.69
- Revenue Growth
- ARQQ N/A
- BWAY 29.04
- 52 Week Low
- ARQQ $3.72
- BWAY $5.13
- 52 Week High
- ARQQ $52.79
- BWAY $11.79
- Technical
- Relative Strength Index (RSI)
- ARQQ 51.82
- BWAY 47.80
- Support Level
- ARQQ $15.00
- BWAY $8.61
- Resistance Level
- ARQQ $17.08
- BWAY $9.09
- Average True Range (ATR)
- ARQQ 1.05
- BWAY 0.38
- MACD
- ARQQ 0.14
- BWAY 0.05
- Stochastic Oscillator
- ARQQ 53.22
- BWAY 58.73
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product QuantumCloud. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. The company operates and generates its revenue from UK.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.